Dilute topical proparacaine for pain relief after photorefractive keratectomy

Ophthalmology. 1997 Aug;104(8):1327-32. doi: 10.1016/s0161-6420(97)30139-0.

Abstract

Purpose: The purpose of the study is to determine whether there is a nonanesthetic and nontoxic concentration of topical proparacaine that can be applied repeatedly to the cornea to reduce pain after photorefractive keratectomy (PRK).

Methods: Part I: To determine a nonanesthetic concentration, the corneal sensitivity of 50 healthy volunteers was assessed using aesthesiometry before and after a drop of either 0.01%, 0.025%, 0.05%, 0.1%, or 0.2% topical proparacaine. Ten volunteers similarly were tested with multiple doses of 0.05% proparacaine. To evaluate toxicity, ten healthy volunteers self-administered 0.05% proparacaine to one eye and placebo to the other eye every 15 minutes for 12 hours on day 1 and every hour for 12 hours on days 2 through 7. Subjects were assessed throughout the week using visual acuity, slitlamp examination, aesthesiometry, and ultrasonic pachometry. Part II: In a prospective, double-masked study, 34 patients who underwent PRK (48 eyes) self-administered either topical 0.05% proparacaine or placebo for 1 week after PRK as needed to reduce pain. Patients recorded their pain score before and after drop use and answered a pain-relief questionnaire.

Results: Part I: Proparacaine concentrations greater than or equal to 0.1% eliminated sensation from some corneas; concentrations of less than or equal to 0.05% were never fully anesthetic. No corneal toxicity was observed except for some minimal punctate staining in both treatment and placebo eyes. Part II: Patients in the treatment group had significantly more pain relief (P < 0.001) for a longer period (P < 0.001) than did patients in the control group. Average change in pain score was significantly greater in the treatment group (P < 0.002). No significant difference in the number of days needed to reach complete epithelial healing was found between the two groups (P < 0.18).

Conclusions: Dilute (0.05%) topical proparacaine is nonanesthetic and nontoxic, and can be used safely for at least 1 week to reduce pain after PRK.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Anesthetics, Local / administration & dosage*
  • Anesthetics, Local / therapeutic use
  • Double-Blind Method
  • Drug Administration Schedule
  • Humans
  • Lasers, Excimer
  • Osmolar Concentration
  • Pain, Postoperative / therapy*
  • Palliative Care*
  • Photorefractive Keratectomy*
  • Propoxycaine / administration & dosage*
  • Propoxycaine / therapeutic use
  • Prospective Studies
  • Treatment Outcome

Substances

  • Anesthetics, Local
  • proxymetacaine
  • Propoxycaine